Journal of Thrombosis and Thrombolysis

, Volume 47, Issue 1, pp 109–112 | Cite as

Analyzing the impact of systems-based hematologist in the healthcare system at an academic medical center

  • Ming Y. LimEmail author
  • Charles S. Greenberg


Over the next decade, there is a predicted shortage of nonmalignant hematologist to maintain the workforce in the United States. To address this, the American Society of Hematology described the creation of the healthcare systems-based hematologist (SBH). The role of SBH has the potential to provide high-value, cost-conscious care to the healthcare system. In 2011, an Anticoagulation and Bleeding Management Medical Directorship position for a SBH was created at our healthcare system. We described our 6-year experience as SBH at a 750-bed tertiary academic medical center to improve clinical outcomes while reducing costs. Via four different initiatives, we were able to provide high-value, cost-conscious care as SBH by reducing cost of heparin-induced thrombocytopenia management, optimizing blood product utilization using goal-directed algorithms, reducing inappropriate thrombophilia testing and improving inferior vena cava filter retrieval rates. To ensure continuing success as a SBH, business plans need to include education, enforcement, monitoring, feedback, validation of safety and outcomes and a shared vision among leadership.


Cost savings Healthcare system Quality improvement 



All authors participated in the writing of the manuscript, and have seen and approved the submitted version. All authors were involved in the conception and design of the study, and the analysis of the data.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

For this type of study formal consent is not required.


  1. 1.
    Wallace PJ, Connell NT, Abkowitz JL (2015) The role of hematologists in a changing United States health care system. Blood 125:2467–2470CrossRefGoogle Scholar
  2. 2.
    Pierce W, Mazur J, Greenberg C, Mueller J, Foster J, Lazarchick J (2013) Evaluation of heparin-induced thrombocytopenia (HIT) laboratory testing and the 4Ts scoring system in the intensive care unit. Ann Clin Lab Sci 43:429–435Google Scholar
  3. 3.
    Lim MY, Foster J, Rourk A, Greenberg CS (2018) Initial and long term impact of a multi-disciplinary task force in the diagnosis and management of heparin-induced thrombocytopenia. J Thromb Thrombolysis 45:130–134CrossRefGoogle Scholar
  4. 4.
    Vaughn CD, Mazur J, Foster J, Lazarchick J, Boylan A, Greenberg CS (2014) Implementation of a heparin-induced thrombocytopenia management program reduces the cost of diagnostic testing and pharmacologic treatment in an academic medical center. Blood 124:Abstract 4848Google Scholar
  5. 5.
    Greenberg CS, Vaughn C, Meserve J, Reuben A, Lim MY, Squires JE (2016) Hematology guided correction of coagulation defects using rotem assays in cirrhosis can reduce the use of fresh frozen plasma prior to invasive procedures. Blood 128:Abstract 2341CrossRefGoogle Scholar
  6. 6.
    Greenberg CS, Vaughn C, Boylan A et al (2015) Analyzing the impact of implementing a systems-based hematologist into the healthcare delivery system at an academic medical center. Blood 126:Abstract 4467Google Scholar
  7. 7.
    Patel IJ, Davidson JC, Nikolic B et al (2012) Consensus guidelines for periprocedural management of coagulation status and hemostasis risk in percutaneous image-guided interventions. J Vasc Interv Radiol 23:727–736CrossRefGoogle Scholar
  8. 8.
    Shah A, Amarapurkar D, Dharod M et al (2015) Coagulopathy in cirrhosis: a prospective study to correlate conventional tests of coagulation and bleeding following invasive procedures in cirrhotics. Indian J Gastroenterol 34:359–364CrossRefGoogle Scholar
  9. 9.
    De Pietri L, Bianchini M, Montalti R et al (2016) Thrombelastography-guided blood product use before invasive procedures in cirrhosis with severe coagulopathy: a randomized, controlled trial. Hepatology 63:566–573CrossRefGoogle Scholar
  10. 10.
    Shander A, Ozawa S, Hofmann A (2016) Activity-based costs of plasma transfusions in medical and surgical inpatients at a US hospital. Vox Sang 111:55–61CrossRefGoogle Scholar
  11. 11.
    Lim MY, Greenberg CS (2018) Inpatient thrombophilia testing: impact of healthcare system technology and targeted clinician education on changing practice patterns. Vasc Med 23:78–79CrossRefGoogle Scholar
  12. 12.
    Lim MY, Vaughn C, Shane LT, Greenberg CS (2016) Strategies to improve safety and outcomes utilizing systems-based hematologists in IVC filter placement and management in an Academic Medical Center. Blood 128:Abstract 4739Google Scholar
  13. 13.
    Bracewell S, Kuhlman T, Guimaraes MS et al. Quality improvement (QI) project to ensure appropriate follow-up for patients post inferior vena cava filter (IVCF) placement. Abstract E-057. Papers.pdf. Accessed 3 Oct 2018

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Division of Hematology/Oncology, Department of MedicineMedical University of South CarolinaCharlestonUSA

Personalised recommendations